Background The success of antiretroviral therapy (ART) has led to dramatic changes in
causes of morbidity and mortality in HIV-infected individuals. As chronic disease rates have …

The proportion of overweight and obese adults in the United States and Canada has
increased over the past decade, but temporal trends in body mass index (BMI) and weight …

Data on weight gain and the progression to overweight/obesity in HIV-infected persons
during initial combination antiretroviral therapy (cART) are limited, and comparisons to the …

Background. The factors that contribute to increasing obesity rates in human
immunodeficiency virus (HIV)-positive persons and to body mass index (BMI) increase that …

Background The prevalence and factors associated with overweight/obesity among human
immunodeficiency virus (HIV)-infected persons are unknown. Methods We evaluated …

Background. Weight gain after antiretroviral therapy (ART) initiation is common, but its
implication for mortality is unknown. We evaluated weight change in the first year after ART …

Since the advent of highly active antiretroviral therapy (HAART), studies have been
conflicting regarding weight information among patients with HIV. We performed a …

Identifying risk factors associated with overweight and obesity in HIV-infected patients. A
cross-sectional study analyzing data from patients attending an HIV outpatient unit …

Although more than one in two HIV-infected persons may develop central fat accumulation
soon after commencing antiretroviral therapy, the association between antiretroviral therapy …

Background: Obesity is prevalent among HIV-infected individuals on antiretroviral therapy
(ART). Cross-sectional studies have suggested that HIV-infected women are more likely to …